![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » AZ BOSS SAYS UK IS A 'DOG' MARKET
AZ BOSS SAYS UK IS A 'DOG' MARKET
June 27, 2005
The chief executive of AstraZeneca has warned that the pharmaceutical industry will direct more of its future investment to the US and Asia if the current uncompetitive climate persists in Europe. Sir Tom McKillop, who runs the Anglo-Swedish pharmaceutical giant valued at £37 billion, said he wasn't threatening to move his company, but pointed out that the continent faced "slow atrophy" as the sector raced ahead in other destinations. He said the UK and Scotland are "increasingly becoming an unattractive place to be" for his industry, adding that Britain was one of the slowest adopters of new medicines and products in the developed world.
BigNews Network (http://feeds.bignewsnetwork.com/redir.php?jid=e184a780506a76ef&cat=6dcd932030878143)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct